Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cholera Vaccine
Biosafety aspects of live oral Vibrio cholerae vaccine strain examined
September 8th, 2004
Researchers examine the biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR in a recent issue of the journal Vaccine. "The development of live attenuated vaccines, allowing for the safe and effective immunization at mucosal surfaces, is a strategy of great interest for vaccinologists. The main advantage of this approach over conventional parenteral vaccines is the induction of strong mucosal immune responses, allowing targeting of the pathogen at the initial point of contact with the host. Further advantages include the ease of administration, high acceptance by vaccines, and relatively low production costs,"...
Source: Vaccine Weekly (2004-09-08)
|
